In this study, we report on a novel mechanism for the RBP MSI1—the 3′UTR- and microRNA (miRNA)-dependent downregulation of CD44 mRNA expression in GBM, which is inhibited by luteolin, previously reported to impair the MSI1–RNA association in GBM-derived cells [17]. Here, MSI1 is linked to glioblastoma.